2C-x

This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it.

2C-x is the general name for the family of synthetic phenethylamines originally studied by Alexander Shulgin. Shulgin first synthesized most of the 2C-x chemicals in the 1970s and later published his findings in his book PiHKAL. The 2C-x chemicals vary in effect from being totally inactive to fully psychedelic.

The general structure for a 2C-x compound

List of 2C-x compunds

Compound	R4	Structure
2C-B	Br
2C-C	Cl
2C-D	CH3
2C-E	CH2CH3
2C-H	H
2C-I	I
2C-iP	CH(CH3)2
2C-P	CH2CH2CH3
2C-TFM	CF3
2C-T-2	SCH2CH3
2C-T-4
2C-T-7	SCH2CH2CH3
2C-T-21	SCH2CH2

Health effects, potential addiction and tolerance

The 2C-x chemicals, as with many other serotonergic psychedelics, should not be taken in combination with SSRIs (selective serotonin reuptake Inhibitor) or tricyclic antidepressants in general to avoid Serotonin Syndrome, a potentially life-threatening condition in which an abundance of serotonin is built up the body, causing many physical and cognitive health problems.

Legal status

• USA: In the US, most of the 2C-x chemicals are Schedule I under the American Food and Drug Administration Safety and Innovation Act of 2012 and the Federal Analogue Act.
• Australia: Australia has a blanket ban over all substituted phenethylamines including the entire 2C-X family.
• Switzerland: Most 2C-x drugs are illegal to possess, produce and sell.
• Canada: All 2C-x phenethylamines are schedule III in Canada.

See also

• Responsible use
• DOx
• 25x-NBOMe
• Psychedelics
• Phenethylamines

External links

• 2C (Wikipedia)

Literature

• Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. (2013). 2C or not 2C: Phenethylamine Designer Drug Review. Journal of Medical Toxicology, 9(2), 172-178. https://doi.org/10.1007/s13181-013-0295-x